Loading LYEL charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading LYEL comparable companies…
| LYELLyell Immunopharma, Inc.(opens in a new tab) | $0.26B | $0.00B | −55.0% | — | −949981.5% | 9553.28× | — |
|---|---|---|---|---|---|---|---|
| KZIAKazia Therapeutics Ltd(opens in a new tab) | $0.93B | $0.00B | −98.2% | — | — | 34313.31× | — |
| IFRXInflaRx N.V.(opens in a new tab) | — | $0.00B | −81.5% | −24677.9% | −71182.1% | — | — |
| JUNSJupiter Neurosciences, Inc.(opens in a new tab) | $0.00B | — | — | — | — | — | — |
| IBOImpact Biomedical Inc.(opens in a new tab) | — | $0.00B | — | — | −14597.1% | — | 4.2× |
| Medianpeers, excl. LYEL | $0.47B | $0.00B | −89.9% | −24677.9% | −42889.6% | 34313.31× | 4.2× |